Stayce Harris - BlackRock Health Independent Trustee
| BME Etf | USD 40.68 0.21 0.52% |
| Age | 62 |
| Tenure | 4 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/24022 |
Stayce Harris Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stayce Harris against BlackRock Health etf is an integral part of due diligence when investing in BlackRock Health. Stayce Harris insider activity provides valuable insight into whether BlackRock Health is net buyers or sellers over its current business cycle. Note, BlackRock Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stayce Harris over three months ago Acquisition by Stayce Harris of tradable shares of BlackRock Income at 11.8 subject to Rule 16b-3 | ||
Stayce Harris over three months ago Acquisition by Stayce Harris of tradable shares of BlackRock Floating at 13.06 subject to Rule 16b-3 | ||
Stayce Harris over three months ago Acquisition by Stayce Harris of tradable shares of BlackRock MIT at 10.7342 subject to Rule 16b-3 | ||
Stayce Harris over three months ago Acquisition by Stayce Harris of tradable shares of BlackRock Long at 10.1987 subject to Rule 16b-3 |
BlackRock Health Management Efficiency
BlackRock Health's management efficiency ratios could be used to measure how well BlackRock Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Cynthia Egan | Blackrock Innovation Growth | 66 | |
| R Hubbard | Blackrock Innovation Growth | 63 | |
| Jonathan Diorio | Blackrock Enhanced Capital | 41 | |
| R Hubbard | Blackrock Resources Commodities | 62 | |
| Richard Froio | Eaton Vance Tax Managed | 53 | |
| Dana DeVivo | Cohen And Steers | 39 | |
| Catherine Lynch | BlackRock Science Tech | 60 | |
| Jay Fife | Blackrock Innovation Growth | 51 | |
| W Kester | Blackrock Resources Commodities | 70 | |
| Jonathan Diorio | BlackRock Science Tech | 41 | |
| Deidre Walsh | Eaton Vance Enhanced | 50 | |
| Scott Wennerholm | Eaton Vance Tax Managed | 62 | |
| Keith Quinton | Eaton Vance Tax Managed | 63 | |
| Eric Stein | Eaton Vance Enhanced | 41 | |
| Robert Fairbairn | Blackrock Resources Commodities | 56 | |
| George Batejan | Columbia Seligman Premium | 67 | |
| Jason Yablon | Cohen Steers Qualityome | 41 | |
| Keith Quinton | Eaton Vance Tax | 63 | |
| Robert Fairbairn | BlackRock Science Tech | 56 | |
| Jeffrey Lee | BlackRock Health Sciences | N/A | |
| Deidre Walsh | Eaton Vance Enhanced | 50 | |
Management Performance
| Return On Equity | 0.0901 | ||||
| Return On Asset | 0.0017 |
BlackRock Health Sciences Money Managers
| CFA CFA, Portfolio Mang | ||
| Erin Xie, Portfolio Manager | ||
| Robert Hubbard, Independent Trustee | ||
| Karen Robards, Independent Vice Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer and Anti- Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Xiang Liu, Portfolio Manager | ||
| Cynthia Egan, Independent Trustee | ||
| Kyle CFA, Portfolio Manager | ||
| Jay Fife, Treasurer | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Christopher Accettella, Portfolio Manager | ||
| Thomas CFA, Portfolio Manager | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Jeffrey Lee, Portfolio Manager | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0901 | ||||
| Return On Asset | 0.0017 | ||||
| Profit Margin | 6.84 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 565.34 M | ||||
| Shares Outstanding | 13.26 M | ||||
| Shares Owned By Institutions | 23.14 % | ||||
| Number Of Shares Shorted | 29.01 K | ||||
| Price To Earning | 6.69 X | ||||
| Price To Book | 0.87 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.